MOD GRF 1-29
CJC without DAC. Pulsatile, on demand.
- Sizes available
- —
- Lab certificate (COA)
- Arrives with shipment
· Research-grade only · Not for human consumption · 21+ ·
CJC-1295 no-DAC variant. Short half-life, natural GH pulse.
Mechanism · Modified GRF[1-29] without DAC modification. Half-life ~30 min.
Best for. Not for.
Best for
- Users who prefer a pulsatile GH pattern (natural physiology).
- Anyone who experienced CJC-DAC long half-life side effects such as water retention.
- Users on a multiple-daily-injection schedule.
Not for
- Children or adolescents (epiphyseal closure).
- Active malignancy, pregnancy, or nursing.
- Users who find multiple daily injections burdensome.
Mechanism, dose, ramp, risk.
- Mechanism
- Modified GRF, no-DAC version. Pulsatile GH release for natural pattern.Source · PEPVERA editorial
- Target dose
- 100 mcg, 2-3x daily.Source · PEPVERA editorial
- Ramp
- 12-Week cycle.Source · PEPVERA editorial
- Risks
- Multiple daily injections.Source · PEPVERA editorial
Compared to its siblings.
MOD GRF 1-29
CJC-1295 no-DAC variant. Short half-life, natural GH pulse.
Pros
- · Physiologic pulsatile GH pattern versus CJC-1295 DAC baseline.
- · Better peptide stability than sermorelin.
Cons
- · Multiple daily injections versus weekly CJC-1295 dosing.
- · No FDA historical track record like sermorelin's Geref.
CJC-1295
DAC variant. Weekly injection, sustained baseline.
Pros
- · Weekly convenience
Cons
- · Non-physiological baseline GH
See CJC-1295 →
Sermorelin
Original GHRH analog (Geref). Short half-life.
Pros
- · FDA historical track record
Cons
- · Daily injection burden
See Sermorelin →
COA per supplier
Published, in-house, or shipment-time
Each supplier declares its own HPLC floor and COA policy. The per-supplier verifier appears on the certificate page; refund and shipping terms vary by supplier and are shown on the supplier listing.
Compare 0 suppliers
No verified suppliers yet for this compound.
Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.
Risk
Multiple daily injections. These pass with discipline. They do not pass with bravado.
Source · PEPVERA editorialDiscipline
12-Week cycle.
Source · PEPVERA editorialWellness
Hydrate. Eat protein. Sleep eight. Hold a dose for at least two weeks before ascending.
Anti-patterns
- · Do not pair with stimulants late in the day.
- · Do not break the cycle without a planned taper.
- · Do not exceed the dose to chase a deeper sleep response.
Crisis
If the ramp triggers severe anxiety, anhedonia, or persistent gastrointestinal disturbance, stop. Resume after two weeks at half the prior dose. The discipline is the slow climb.
Week 1–2
100 mcg, 2-3x daily.
Initiation
Week 3–4
100 mcg, 2-3x daily.
Signal emerges
Week 5–8
100 mcg, 2-3x daily.
Hold
Week 9–12
Cycle review
Assess
Draw 20 units.
0.2 mg = 0.20 mL at 1.00 mg/mL. 10.0 doses per vial.
apex · II
MOD GRF 1-29 · 2mg